BCART.BR - Biocartis Group NV

Brussels - Brussels Delayed price. Currency in EUR
Currency in EUR

Valuation measures4

Market cap (intra-day) 56.51M
Enterprise value 153.94M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.67
Price/book (mrq)N/A
Enterprise value/revenue 2.68
Enterprise value/EBITDA -3.50

Trading information

Stock price history

Beta (5Y monthly) 1.51
52-week change 3-71.72%
S&P500 52-week change 33.90%
52-week high 32.1200
52-week low 30.5120
50-day moving average 30.6130
200-day moving average 30.8095

Share statistics

Avg vol (3-month) 399.66k
Avg vol (10-day) 346.62k
Shares outstanding 593.47M
Implied shares outstanding 6N/A
Float 886.28M
% held by insiders 16.64%
% held by institutions 127.71%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)31 Dec 2022


Profit margin -112.77%
Operating margin (ttm)-79.12%

Management effectiveness

Return on assets (ttm)-22.33%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)57.98M
Revenue per share (ttm)0.96
Quarterly revenue growth (yoy)-2.00%
Gross profit (ttm)-10.22M
EBITDA -40.78M
Net income avi to common (ttm)-65.38M
Diluted EPS (ttm)-1.1100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)26.12M
Total cash per share (mrq)0.28
Total debt (mrq)122.36M
Total debt/equity (mrq)N/A
Current ratio (mrq)1.65
Book value per share (mrq)-0.33

Cash flow statement

Operating cash flow (ttm)-44.85M
Levered free cash flow (ttm)-28.54M